Innovative Therapeutics BrainQ Technologies is developing AI-powered electromagnetic therapy aimed at reducing disability from neuro disorders and stroke, positioning it as a cutting-edge solution provider in neurorehabilitation markets.
Growth & Investment The company secured a significant $40 million investment from Hanaco Ventures and partners, reflecting strong investor confidence and potential for scaling its medical device offerings globally.
Regulatory Advancements Achieving FDA Breakthrough Device Designation offers BrainQ early access to regulatory pathways, facilitating faster commercialization which presents opportunities for healthcare providers adopting innovative neurotherapy devices.
Strategic Leadership The addition of notable scientific leaders such as Eilon D. Kirson to the board enhances BrainQ’s credibility and positions it strongly for partnership with research institutions and healthcare providers.
Technology & Collaborations Leveraging advanced AI and brain-computer interface technology, BrainQ's platform makes it a potential partner for hospitals, clinics, and rehabilitation centers seeking innovative neurotherapies and technological solutions.
BrainQ Technologies uses 8 technology products and services including Amazon Web Services, jsDelivr, Open Graph, and more. Explore BrainQ Technologies's tech stack below.
| BrainQ Technologies Email Formats | Percentage |
| First.Last@brainqtech.com | 39% |
| First@brainqtech.com | 13% |
| Last@brainqtech.com | 9% |
| First.Last@brainqtech.com | 39% |
Medical Equipment ManufacturingIsrael11-50 Employees
At BRAIN.Q (BrainQ technologies) we are on a Quest to provide a breakthrough, evidence-based Brain Health Therapeutics platform, addressing the ultimate frontier that will dictate the course of how we live and age.
Company Overview
Funding & FinancialsBrainQ Technologies's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsBrainQ Technologies's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com